Nifty

:

18696.10

Sensex

:

62868.50

-116.40 (-0.62%)
-415.69 (-0.66%)

Login

Nifty
Sensex

:
:

18696.10
62868.50

-116.40 (-0.62%)
-415.69 (-0.66%)

JB Chemicals & Pharmaceuticals Ltd.

Pharmaceuticals & Drugs - Domestic

Rating :

59/99

BSE: 506943 | NSE: JBCHEPHARM

Watchlist

NSE BSE

2018.00

01-Dec-2022

Day's Open
Day's High
Day's Low
Previous Close

2024.90
2030.00
2011.90
2018.20

Volume
Traded Value (lacs)
52 Week High
52 Week Low

31935
645.49
2150.00
1342.20

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

15,617.42
40.63
2

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

15,585.21
0.82%
6.75

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

10.84
11.39
10.96

EBITDA CAGR (%)

10 Years
5 Years
3 Years

17.78
22.20
7.52

PAT CAGR (%)

10 Years
5 Years
3 Years

17.11
22.74
12.31

P:E (Median)

8 Years
5 Years
3 Years

19.78
20.41
26.69

P:BV (Average)

8 Years
5 Years
3 Years

3.33
3.99
5.36

EV:EBITDA (Average)

8 Years
5 Years
3 Years

13.00
14.26
17.36

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Sep 22 Sep 21 Var% Jun 22 Jun 21 Var% Mar 22 Mar 21 Var% Dec 21 Dec 20 Var%
Net Sales 739.96 526.73 40.48% 716.13 546.30 31.09% 583.58 490.25 19.04% 533.27 500.34 6.58%
Expenses 574.17 412.05 39.34% 548.15 387.99 41.28% 461.99 364.38 26.79% 418.93 333.74 25.53%
EBITDA 165.79 114.68 44.57% 167.98 158.31 6.11% 121.58 125.87 -3.41% 114.34 166.60 -31.37%
EBIDTM 22.41% 21.77% 23.46% 28.98% 20.83% 25.67% 21.44% 33.30%
Other Income 1.72 19.56 -91.21% 0.51 12.88 -96.04% 1.86 25.30 -92.65% 4.31 55.86 -92.28%
Interest 7.60 1.18 544.07% 5.79 0.89 550.56% 1.58 0.68 132.35% 1.30 1.08 20.37%
Depreciation 27.71 15.40 79.94% 25.69 17.48 46.97% 21.79 16.19 34.59% 16.62 17.05 -2.52%
PBT 132.20 117.66 12.36% 137.01 152.82 -10.35% 100.08 134.30 -25.48% 100.73 204.33 -50.70%
Tax 34.48 29.26 17.84% 35.72 37.51 -4.77% 17.36 31.79 -45.39% 26.16 52.66 -50.32%
PAT 97.72 88.40 10.54% 101.29 115.31 -12.16% 82.72 102.51 -19.31% 74.57 151.67 -50.83%
PATM 13.21% 16.78% 14.14% 21.11% 14.17% 20.91% 13.98% 30.31%
EPS 12.64 11.44 10.49% 13.10 14.92 -12.20% 10.70 13.26 -19.31% 9.65 19.62 -50.82%

Description Sep 22 Sep 21 Var% Jun 22 Jun 21 Var% Mar 22 Mar 21 Var% Dec 21 Dec 20 Var%
Net Sales 809.44 593.01 36.50% 784.81 605.99 29.51% 624.59 528.46 18.19% 600.66 548.22 9.57%
Expenses 624.86 466.26 34.02% 612.05 442.30 38.38% 499.66 404.56 23.51% 472.55 377.22 25.27%
EBITDA 184.58 126.75 45.63% 172.76 163.69 5.54% 124.92 123.90 0.82% 128.11 170.99 -25.08%
EBIDTM 22.80% 21.37% 22.01% 27.01% 20.00% 23.44% 21.33% 31.19%
Other Income 1.34 19.65 -93.18% 0.89 12.97 -93.14% 2.08 25.35 -91.79% 4.53 55.95 -91.90%
Interest 7.96 1.23 547.15% 5.83 0.94 520.21% 1.62 0.69 134.78% 1.34 1.09 22.94%
Depreciation 28.13 15.74 78.72% 26.08 17.85 46.11% 22.11 16.53 33.76% 16.97 17.39 -2.42%
PBT 149.83 129.43 15.76% 141.74 157.87 -10.22% 103.28 132.02 -21.77% 114.33 208.46 -45.15%
Tax 38.75 31.54 22.86% 36.54 38.81 -5.85% 18.31 31.21 -41.33% 30.21 54.18 -44.24%
PAT 111.08 97.89 13.47% 105.20 119.06 -11.64% 84.97 100.81 -15.71% 84.12 154.28 -45.48%
PATM 13.72% 16.51% 13.40% 19.65% 13.60% 19.08% 14.00% 28.14%
EPS 14.36 12.65 13.52% 13.59 15.38 -11.64% 10.98 13.02 -15.67% 10.85 19.94 -45.59%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Net Sales 2,572.94 2,189.88 1,892.00 1,640.74 1,501.19 1,254.99 1,198.69 1,164.94 1,061.42 956.53 816.42 Net Sales Growth 24.68% 15.74% 15.31% 9.30% 19.62% 4.70% 2.90% 9.75% 10.97% 17.16% Cost Of Goods Sold 902.85 743.70 625.76 569.14 536.35 484.27 469.32 470.01 322.91 380.72 341.32 Gross Profit 1,670.09 1,446.18 1,266.24 1,071.61 964.83 770.72 729.38 694.93 738.51 575.81 475.10 GP Margin 64.91% 66.04% 66.93% 65.31% 64.27% 61.41% 60.85% 59.65% 69.58% 60.20% 58.19% Total Expenditure 2,003.24 1,681.15 1,339.66 1,272.50 1,212.75 1,072.79 980.15 939.21 868.48 802.49 705.00 Power & Fuel Cost - 71.36 62.60 61.54 63.29 58.28 54.89 55.28 53.02 46.61 39.75 % Of Sales - 3.26% 3.31% 3.75% 4.22% 4.64% 4.58% 4.75% 5.00% 4.87% 4.87% Employee Cost - 399.06 305.98 293.78 257.98 217.31 187.86 165.96 146.82 131.85 120.13 % Of Sales - 18.22% 16.17% 17.91% 17.19% 17.32% 15.67% 14.25% 13.83% 13.78% 14.71% Manufacturing Exp. - 176.57 134.52 129.40 139.89 130.97 122.68 119.24 223.30 102.28 61.62 % Of Sales - 8.06% 7.11% 7.89% 9.32% 10.44% 10.23% 10.24% 21.04% 10.69% 7.55% General & Admin Exp. - 93.33 54.90 46.11 49.84 49.82 39.08 32.06 29.92 28.78 25.76 % Of Sales - 4.26% 2.90% 2.81% 3.32% 3.97% 3.26% 2.75% 2.82% 3.01% 3.16% Selling & Distn. Exp. - 133.38 99.94 106.58 104.91 59.44 48.83 48.13 47.39 70.48 55.49 % Of Sales - 6.09% 5.28% 6.50% 6.99% 4.74% 4.07% 4.13% 4.46% 7.37% 6.80% Miscellaneous Exp. - 63.76 55.96 65.96 60.48 72.71 57.49 48.54 45.12 41.78 55.49 % Of Sales - 2.91% 2.96% 4.02% 4.03% 5.79% 4.80% 4.17% 4.25% 4.37% 7.46% EBITDA 569.69 508.73 552.34 368.24 288.44 182.20 218.54 225.73 192.94 154.04 111.42 EBITDA Margin 22.14% 23.23% 29.19% 22.44% 19.21% 14.52% 18.23% 19.38% 18.18% 16.10% 13.65% Other Income 8.40 38.80 115.92 49.57 40.23 56.21 49.51 55.68 10.41 37.54 25.96 Interest 16.27 4.95 7.19 3.16 4.57 3.41 5.00 10.29 6.65 5.93 5.24 Depreciation 91.81 71.28 67.36 65.09 54.82 55.95 46.26 40.41 37.60 27.17 24.40 PBT 470.02 471.29 593.71 349.56 269.28 179.04 216.78 230.69 159.10 158.49 107.74 Tax 113.72 110.29 146.62 71.42 87.22 51.04 43.82 51.49 45.52 25.56 22.81 Tax Rate 24.19% 23.40% 24.70% 21.03% 32.39% 28.51% 20.21% 22.32% 28.61% 27.19% 21.17% PAT 356.30 361.00 447.08 268.14 182.06 128.00 172.96 179.20 113.58 68.43 84.94 PAT before Minority Interest 356.30 361.00 447.08 268.14 182.06 128.00 172.96 179.20 113.58 68.43 84.94 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 13.85% 16.48% 23.63% 16.34% 12.13% 10.20% 14.43% 15.38% 10.70% 7.15% 10.40% PAT Growth -22.19% -19.25% 66.73% 47.28% 42.23% -25.99% -3.48% 57.77% 65.98% -19.44% EPS 46.09 46.70 57.84 34.69 23.55 16.56 22.38 23.18 14.69 8.85 10.99

Description TTM Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Net Sales 2,819.50 2,424.24 2,042.52 1,774.73 1,643.20 1,413.77 1,368.32 1,231.58 1,144.21 1,021.86 866.13 Net Sales Growth 23.90% 18.69% 15.09% 8.00% 16.23% 3.32% 11.10% 7.64% 11.97% 17.98% Cost Of Goods Sold 1,013.19 842.93 701.50 630.80 596.46 542.41 552.00 491.41 341.40 413.95 371.52 Gross Profit 1,806.31 1,581.31 1,341.02 1,143.93 1,046.74 871.35 816.32 740.17 802.81 607.92 494.60 GP Margin 64.06% 65.23% 65.66% 64.46% 63.70% 61.63% 59.66% 60.10% 70.16% 59.49% 57.10% Total Expenditure 2,209.12 1,881.63 1,486.35 1,397.15 1,337.36 1,214.64 1,135.93 1,025.55 964.09 873.67 760.48 Power & Fuel Cost - 71.47 62.60 61.54 63.29 58.28 54.89 55.28 53.02 46.61 39.75 % Of Sales - 2.95% 3.06% 3.47% 3.85% 4.12% 4.01% 4.49% 4.63% 4.56% 4.59% Employee Cost - 439.24 340.60 322.92 288.18 251.10 217.34 175.31 159.56 143.67 130.05 % Of Sales - 18.12% 16.68% 18.20% 17.54% 17.76% 15.88% 14.23% 13.94% 14.06% 15.02% Manufacturing Exp. - 194.00 148.68 140.70 150.49 139.83 131.45 119.35 223.53 102.44 61.75 % Of Sales - 8.00% 7.28% 7.93% 9.16% 9.89% 9.61% 9.69% 19.54% 10.02% 7.13% General & Admin Exp. - 100.76 56.35 48.14 52.97 53.96 42.26 34.82 32.46 31.69 27.94 % Of Sales - 4.16% 2.76% 2.71% 3.22% 3.82% 3.09% 2.83% 2.84% 3.10% 3.23% Selling & Distn. Exp. - 161.80 113.22 116.95 113.59 87.44 78.27 72.72 75.13 73.59 56.04 % Of Sales - 6.67% 5.54% 6.59% 6.91% 6.18% 5.72% 5.90% 6.57% 7.20% 6.47% Miscellaneous Exp. - 71.42 63.38 76.11 72.38 81.61 59.72 76.65 79.01 61.72 56.04 % Of Sales - 2.95% 3.10% 4.29% 4.40% 5.77% 4.36% 6.22% 6.91% 6.04% 8.48% EBITDA 610.37 542.61 556.17 377.58 305.84 199.13 232.39 206.03 180.12 148.19 105.65 EBITDA Margin 21.65% 22.38% 27.23% 21.28% 18.61% 14.09% 16.98% 16.73% 15.74% 14.50% 12.20% Other Income 8.84 40.07 116.62 50.90 41.44 55.29 50.16 56.65 10.89 37.70 27.87 Interest 16.75 5.12 7.24 3.26 4.65 3.49 5.37 10.65 6.82 5.93 5.28 Depreciation 93.29 72.66 68.67 66.32 55.64 56.97 47.22 41.22 38.64 28.02 24.66 PBT 509.18 504.90 596.89 358.89 286.99 193.95 229.94 210.82 145.55 151.94 103.57 Tax 123.81 118.86 148.36 76.50 93.02 55.23 45.55 49.58 45.14 25.95 24.13 Tax Rate 24.32% 23.54% 24.86% 21.93% 32.41% 28.48% 19.81% 23.52% 31.01% 29.68% 23.30% PAT 385.37 385.36 447.96 272.04 193.47 138.34 184.06 161.14 100.41 61.50 79.44 PAT before Minority Interest 384.84 386.04 448.52 272.39 193.97 138.72 184.40 161.24 100.41 61.50 79.44 Minority Interest -0.53 -0.68 -0.56 -0.35 -0.50 -0.38 -0.34 -0.10 0.00 0.00 0.00 PAT Margin 13.67% 15.90% 21.93% 15.33% 11.77% 9.79% 13.45% 13.08% 8.78% 6.02% 9.17% PAT Growth -18.36% -13.97% 64.67% 40.61% 39.85% -24.84% 14.22% 60.48% 63.27% -22.58% EPS 49.85 49.85 57.95 35.19 25.03 17.90 23.81 20.85 12.99 7.96 10.28

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Shareholder's Funds 2,103.67 1,806.46 1,445.29 1,484.56 1,453.39 1,387.86 1,222.71 1,016.31 1,047.81 1,009.00 Share Capital 15.46 15.46 15.46 16.05 16.71 16.96 16.96 16.96 16.95 16.94 Total Reserves 2,025.56 1,791.00 1,429.83 1,468.52 1,436.67 1,370.90 1,205.74 999.35 1,030.82 991.95 Non-Current Liabilities 87.06 86.41 73.29 79.08 62.98 41.79 46.07 34.05 32.56 37.45 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.09 0.22 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.40 0.40 7.03 Long Term Provisions 13.22 12.57 7.39 5.73 9.67 8.88 10.20 12.03 12.19 8.23 Current Liabilities 808.02 645.74 493.55 763.27 711.89 666.97 735.89 398.40 261.56 226.38 Trade Payables 196.24 164.02 151.88 111.33 100.22 79.03 68.61 62.31 51.69 51.76 Other Current Liabilities 77.46 86.45 100.73 87.05 112.90 118.08 119.03 82.60 94.00 98.41 Short Term Borrowings 26.32 26.43 29.49 25.80 28.48 48.86 174.40 104.73 81.28 36.77 Short Term Provisions 508.01 368.83 211.45 539.10 470.29 421.00 373.85 148.76 34.59 39.43 Total Liabilities 2,998.75 2,538.61 2,012.13 2,326.91 2,228.26 2,096.62 2,004.67 1,448.76 1,341.93 1,272.83 Net Block 1,203.67 564.60 583.21 552.11 569.91 608.69 369.35 300.87 282.21 294.37 Gross Block 1,796.83 1,108.14 1,105.15 1,011.81 979.68 963.76 679.77 571.73 510.94 497.02 Accumulated Depreciation 593.16 543.54 521.95 459.70 409.78 355.07 310.42 270.86 228.74 202.65 Non Current Assets 1,385.75 742.49 805.74 804.94 781.26 941.36 891.59 604.38 378.00 352.44 Capital Work in Progress 18.68 25.57 16.17 15.09 17.40 3.76 134.89 55.17 46.32 4.81 Non Current Investment 145.69 145.88 202.42 228.84 182.92 318.81 364.38 230.72 38.86 38.98 Long Term Loans & Adv. 16.69 5.62 3.59 8.31 10.00 9.22 22.63 17.62 10.62 14.28 Other Non Current Assets 1.04 0.82 0.36 0.59 1.03 0.88 0.33 0.00 0.00 0.00 Current Assets 1,612.99 1,796.12 1,206.39 1,521.97 1,446.99 1,155.26 1,113.08 844.38 963.93 920.39 Current Investments 0.00 664.97 333.81 360.65 383.77 224.96 247.28 366.78 497.26 394.68 Inventories 349.78 278.91 232.04 208.10 175.81 159.96 133.29 128.47 111.23 89.89 Sundry Debtors 518.05 374.11 344.24 299.85 300.54 265.10 265.67 248.49 248.05 194.64 Cash & Bank 39.67 26.43 11.56 20.77 14.95 7.20 10.71 9.06 10.80 149.11 Other Current Assets 705.49 43.60 18.03 32.49 571.92 498.05 456.13 91.58 96.59 92.07 Short Term Loans & Adv. 649.72 408.10 266.71 600.11 560.72 485.82 453.62 91.20 96.39 91.92 Net Current Assets 804.97 1,150.38 712.84 758.71 735.10 488.29 377.19 445.98 702.37 694.01 Total Assets 2,998.74 2,538.61 2,012.13 2,326.91 2,228.25 2,096.62 2,004.67 1,448.76 1,341.93 1,272.83

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Shareholder's Funds 2,134.12 1,809.72 1,435.49 1,480.12 1,441.56 1,363.67 1,183.84 994.87 1,042.81 1,020.27 Share Capital 15.46 15.46 15.46 16.05 16.71 16.96 16.96 16.96 16.95 16.94 Total Reserves 2,056.01 1,794.27 1,420.03 1,464.08 1,424.84 1,346.70 1,166.87 977.91 1,025.82 1,003.22 Non-Current Liabilities 78.64 72.47 62.72 64.84 45.66 26.98 31.02 32.62 31.93 40.45 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.09 0.22 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.40 0.40 7.03 Long Term Provisions 13.73 12.57 7.39 5.73 9.67 12.56 10.43 12.03 12.19 8.23 Current Liabilities 851.86 686.57 516.19 781.54 736.50 693.46 797.22 459.75 276.27 239.48 Trade Payables 224.48 186.92 167.97 117.37 110.39 98.98 90.85 77.51 60.75 60.51 Other Current Liabilities 81.31 89.82 102.67 93.10 119.75 122.15 138.73 103.74 98.06 101.15 Short Term Borrowings 26.32 32.64 29.49 25.80 29.29 48.86 193.02 126.88 81.71 37.28 Short Term Provisions 519.76 377.17 216.06 545.27 477.06 423.47 374.61 151.62 35.76 40.54 Total Liabilities 3,069.11 2,572.47 2,016.90 2,329.30 2,226.49 2,086.29 2,013.75 1,487.24 1,351.01 1,300.20 Net Block 1,276.99 633.65 651.26 620.93 639.50 679.44 440.22 328.56 310.55 334.41 Gross Block 1,876.20 1,182.55 1,177.43 1,084.83 1,053.76 1,038.55 753.75 601.67 540.54 537.46 Accumulated Depreciation 599.21 548.90 526.17 463.89 414.25 359.10 313.53 273.11 229.99 203.06 Non Current Assets 1,326.12 678.57 740.83 740.80 717.89 879.15 831.58 586.31 370.37 356.49 Capital Work in Progress 18.68 25.57 16.17 15.09 17.40 3.76 134.89 55.17 46.36 4.81 Non Current Investment 12.72 12.91 69.45 95.88 49.96 185.84 231.42 184.83 2.75 2.99 Long Term Loans & Adv. 16.69 5.62 3.59 8.31 10.15 9.43 22.63 17.74 10.71 14.28 Other Non Current Assets 1.04 0.82 0.36 0.59 0.88 0.67 2.43 0.00 0.00 0.00 Current Assets 1,743.00 1,893.89 1,276.08 1,588.51 1,508.59 1,207.14 1,182.16 900.94 980.65 943.71 Current Investments 0.00 664.97 333.81 360.65 383.77 224.96 247.28 366.78 497.26 394.68 Inventories 409.96 347.45 274.67 243.76 213.73 200.17 187.98 150.27 134.40 104.53 Sundry Debtors 555.69 389.02 345.43 308.22 300.73 265.97 272.64 262.35 235.51 191.27 Cash & Bank 58.53 30.85 30.95 36.80 29.92 13.39 12.90 25.19 11.81 156.23 Other Current Assets 718.82 45.95 18.89 33.23 580.44 502.66 461.34 96.35 101.68 96.99 Short Term Loans & Adv. 661.39 415.66 272.33 605.85 567.50 488.30 458.83 95.97 101.48 96.84 Net Current Assets 891.14 1,207.33 759.88 806.97 772.10 513.68 384.94 441.19 704.37 704.23 Total Assets 3,069.12 2,572.46 2,016.91 2,329.31 2,226.48 2,086.29 2,013.74 1,487.25 1,351.02 1,300.20

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Cash From Operating Activity 147.10 335.43 271.95 192.63 115.87 177.58 170.87 143.03 -11.65 80.41 PBT 471.29 593.71 339.56 269.28 179.04 216.78 230.69 159.10 93.99 107.74 Adjustment 97.15 -56.41 15.19 26.87 14.73 10.01 -9.63 35.94 14.11 -6.43 Changes in Working Capital -294.22 -61.45 4.34 -42.44 -39.95 -0.30 1.15 -14.04 -93.19 0.67 Cash after chg. in Working capital 274.22 475.85 359.10 253.70 153.82 226.50 222.22 181.00 14.90 101.98 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -127.12 -140.41 -87.15 -61.08 -37.95 -48.91 -51.34 -37.97 -26.55 -21.57 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity 4.18 -230.68 23.80 -27.93 -23.97 -42.45 -51.69 -121.72 -138.77 -111.73 Net Fixed Assets -681.80 -12.39 -94.42 -29.82 -29.56 -152.86 -187.76 -69.64 -55.43 -41.77 Net Investments 665.16 -274.62 53.26 -22.80 -22.92 67.89 -14.16 -61.38 -102.46 -95.95 Others 20.82 56.33 64.96 24.69 28.51 42.52 150.23 9.30 19.12 25.99 Cash from Financing Activity -137.85 -86.90 -305.48 -155.66 -59.44 -164.84 -97.46 -23.06 12.12 -30.93 Net Cash Inflow / Outflow 13.42 17.86 -9.73 9.05 32.45 -29.71 21.72 -1.75 -138.31 -62.25 Opening Cash & Equivalents 24.26 6.37 16.11 7.09 -25.36 4.35 -14.50 10.80 149.11 211.36 Closing Cash & Equivalent 37.69 24.26 6.37 16.11 7.09 -25.36 7.23 9.06 10.80 149.11

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Cash From Operating Activity 170.13 314.78 275.75 194.33 122.92 201.13 140.41 126.66 -13.98 84.20 PBT 504.90 596.89 348.89 286.99 193.95 229.94 212.23 145.55 87.44 103.57 Adjustment 102.37 -46.17 7.95 23.72 16.91 13.11 -1.40 38.51 20.75 -4.40 Changes in Working Capital -302.52 -94.21 9.70 -51.47 -47.07 5.92 -16.96 -19.52 -93.71 9.47 Cash after chg. in Working capital 304.75 456.50 366.55 259.24 163.79 248.97 193.88 164.53 14.49 108.65 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -134.62 -141.72 -90.80 -64.91 -40.87 -47.84 -53.47 -37.87 -28.47 -24.45 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity 2.32 -230.68 23.93 -27.67 -20.68 -45.31 -27.62 -111.89 -142.50 -116.05 Net Fixed Assets -681.80 -12.39 -94.42 -29.82 -29.56 -152.86 -187.76 -69.64 -55.43 -41.77 Net Investments 665.16 -274.62 53.26 -22.80 -22.92 67.89 -14.16 -61.38 -102.46 -95.95 Others 18.96 56.33 65.09 24.95 31.80 39.66 174.30 19.13 15.39 21.67 Cash from Financing Activity -138.39 -87.42 -306.05 -155.74 -59.52 -183.84 -99.62 -1.39 12.04 -31.45 Net Cash Inflow / Outflow 34.07 -3.31 -6.38 10.92 42.72 -28.02 13.17 13.38 -144.43 -63.30 Opening Cash & Equivalents 22.47 25.75 32.14 21.24 -21.47 6.54 -5.46 11.81 156.23 219.53 Closing Cash & Equivalent 56.54 22.47 25.75 32.14 21.24 -21.47 9.42 25.19 11.81 156.23

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Book Value (Rs.) 264.10 233.75 187.02 185.02 173.91 163.62 144.15 119.84 123.66 119.10 ROA 13.04% 19.65% 12.36% 7.99% 5.92% 8.43% 10.38% 8.14% 5.23% 6.95% ROE 18.77% 27.50% 18.30% 12.39% 9.01% 13.25% 16.01% 11.01% 6.65% 8.66% ROCE 24.04% 36.33% 22.96% 18.30% 12.50% 15.65% 19.14% 14.65% 9.09% 10.85% Fixed Asset Turnover 1.51 1.71 1.55 1.51 1.29 1.46 1.86 1.99 1.92 1.80 Receivable days 74.35 69.29 71.64 72.99 82.25 80.81 80.55 84.22 83.37 71.93 Inventory Days 52.39 49.29 48.96 46.67 48.83 44.65 41.01 40.66 37.88 39.88 Payable days 88.41 92.13 39.24 32.65 32.75 29.00 27.03 25.03 24.67 24.46 Cash Conversion Cycle 38.34 26.45 81.36 87.01 98.33 96.46 94.52 99.85 96.57 87.35 Total Debt/Equity 0.01 0.01 0.02 0.02 0.02 0.04 0.14 0.10 0.09 0.05 Interest Cover 96.24 83.55 108.34 59.98 53.45 44.35 23.41 24.93 16.84 21.55

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Book Value (Rs.) 268.04 234.17 185.75 184.47 172.50 160.77 139.57 117.31 123.07 119.21 ROA 13.69% 19.55% 12.53% 8.52% 6.43% 8.99% 9.21% 7.08% 4.64% 6.36% ROE 19.89% 27.64% 18.69% 13.28% 9.89% 14.48% 14.80% 9.86% 5.99% 8.07% ROCE 25.48% 36.53% 23.71% 19.59% 13.70% 16.87% 17.72% 13.49% 8.50% 10.41% Fixed Asset Turnover 1.59 1.73 1.57 1.54 1.35 1.53 1.82 2.03 1.92 1.76 Receivable days 71.12 65.62 67.22 67.63 73.15 71.84 79.28 78.41 75.30 68.16 Inventory Days 57.02 55.59 53.31 50.81 53.43 51.77 50.12 44.83 42.16 42.80 Payable days 89.07 92.33 38.74 32.21 33.66 32.86 32.45 27.82 26.91 26.15 Cash Conversion Cycle 39.07 28.88 81.79 86.23 92.93 90.75 96.95 95.43 90.54 84.81 Total Debt/Equity 0.01 0.02 0.02 0.02 0.02 0.04 0.16 0.13 0.09 0.05 Interest Cover 99.60 83.43 108.09 62.74 56.54 43.81 20.80 22.33 15.74 20.61

Top Investors:

nippon life india trustee ltd-a/c nippon india pharma fund*

invesco india contra fund *

government pension fund global

franklin india smaller companies fund

kotak mahindra life insurance company ltd.

Annual Reports:

News Update:

JB Chemicals & Pharmaceuticals gets USFDA’s nod for Venlafaxine Extended Release Tablets
30th Nov 2022, 16:12 PM

This product is based on OROS technology, an advanced and precision-controlled release mechanism
Read More
JB Chem & Pharma - Quarterly Results
12th Nov 2022, 10:15 AM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback